These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Introduction. Review of major recent findings supporting treatments to control advanced plaques of atherosclerosis. Insull W Am J Med; 2009 Jan; 122(1 Suppl):S1-2. PubMed ID: 19110083 [No Abstract] [Full Text] [Related]
13. Aggressive lipid-lowering therapy and regression of coronary atheroma. Rajaram K JAMA; 2004 Jul; 292(1):39; author reply 39-40. PubMed ID: 15238582 [No Abstract] [Full Text] [Related]
14. Aggressive lipid-lowering therapy and regression of coronary atheroma. van der Harst P; van Gilst WH; Zijlstra F JAMA; 2004 Jul; 292(1):39; author reply 39-40. PubMed ID: 15238583 [No Abstract] [Full Text] [Related]
15. Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial. Nicholls SJ; Puri R; Anderson T; Ballantyne CM; Cho L; Kastelein JJ; Koenig W; Somaratne R; Kassahun H; Yang J; Wasserman SM; Scott R; Ungi I; Podolec J; Ophuis AO; Cornel JH; Borgman M; Brennan DM; Nissen SE JAMA; 2016 Dec; 316(22):2373-2384. PubMed ID: 27846344 [TBL] [Abstract][Full Text] [Related]
16. [When cholesterol lowering drugs should not be too expensive. Statins are especially effective in secondary prevention]. Thomas HP; Kassner U; Steinhagen-Thiessen E MMW Fortschr Med; 2000 Jul; 142(30):33-4. PubMed ID: 10955017 [No Abstract] [Full Text] [Related]
17. [Coronary heart disease prevention. Are there differences in cholesterol synthesis inhibitors?]. Müller-Wieland D; Faust M; Schleifenbaum T; Krone W MMW Fortschr Med; 2000 Jul; 142(30):26-8. PubMed ID: 10955015 [TBL] [Abstract][Full Text] [Related]